tetano
Editor, Senior Moderator
A drug from Japan?s Fujifilm Holdings Corp. has emerged as a candidate for treating the Ebola virus, which has killed nearly 1,000 people in Africa during a recent outbreak.
The drug?a anti-influenza tablet called favipiravir?was created by a Fujifilm subsidiary, Toyama Chemical Co., and approved by the Japanese Ministry of Health, Labor and Welfare in March.
A Fujifilm spokesman said Friday that the company was in talks with the U.S. Food and Drug Administration on how to prepare for trials of the drug in treating Ebola.
?Since Ebola and influenza viruses are the same type, theoretically, the same effects can be expected on Ebola,? said the spokesman. He added, however, that the drug is currently approved to treat only novel and re-emerging influenza viruses.
http://abujavoice.com/favipiravir-another-drug-for-ebola-cure-discovered-in-japan/
The drug?a anti-influenza tablet called favipiravir?was created by a Fujifilm subsidiary, Toyama Chemical Co., and approved by the Japanese Ministry of Health, Labor and Welfare in March.
A Fujifilm spokesman said Friday that the company was in talks with the U.S. Food and Drug Administration on how to prepare for trials of the drug in treating Ebola.
?Since Ebola and influenza viruses are the same type, theoretically, the same effects can be expected on Ebola,? said the spokesman. He added, however, that the drug is currently approved to treat only novel and re-emerging influenza viruses.
http://abujavoice.com/favipiravir-another-drug-for-ebola-cure-discovered-in-japan/